Richard J. Medalie, brought suit under the Medicare Secondary Payer statute (the “MSP”) against the drug companies that developed, manufactured, and marketed the drug Baycol. Following its decision in Stalley v. Catholic Health Initiatives, Nos. 06-3884, 06-4121, 2007 U.S. App. LEXIS 27331, 2007 WL 4165751 (8th Cir. Nov. 27, 2007), the Court held that an MSP action is not a qui tam action. A plaintiff who lacks any injury in fact does not have standing to pursue an MSP action.
Last updated 2/28/2025 The Georgia Power of Attorney Act was enacted in 2017 (HB 221)…
In North Carolina Department of Revenue v. The Kimberley Rice Kaestner 1992 Family Trust, the…
Medicaid is critical for individuals with special needs. It pays for things no one else…
Since 1980, Medicare pays after another responsible entity pays certain health care claims for Medicare…
Many people want to know when they should apply for Social Security (assuming it still…
The Social Security Fairness Act was signed into law on January 5, 2025. Prior to…